GlassScriptPhysician profile
Jenna Warehime
NPI 1851746127
$4,149.72
in general payments reported to CMS, 2019-2025
10 companies · $951 in 2025
The $951 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $73.20 · 2021: $166 · 2022: $616 · 2023: $2,142 · 2024: $202 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,662 · Education: $1,000 · Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,662.42 |
| Education | $1,000.00 |
| Food and Beverage | $631.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,011.28 | 2021-2025 | Interstim, Altaviva |
| Intuitive Surgical, INC. | $1,110.06 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Baxter Healthcare | $405.18 | 2022-2024 | Tisseel, Floseal |
| Axonics, INC. | $229.18 | 2020-2023 | Axonics |
| Boston Scientific Corporation | $127.98 | 2022-2024 | Advantage System |
| Aspira Women'S Health INC | $109.01 | 2022 | |
| Abbvie INC. | $85.14 | 2020-2023 | Botox |
| Allergan, INC. | $30.20 | 2020-2021 | |
| Astellas Pharma US INC | $23.13 | 2022 | |
| Urovant Sciences INC | $18.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Warehime listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.